Magenta Therapeutics Buy Hold or Sell Recommendation
| MGTADelisted Stock | USD 0.82 0.03 3.80% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Magenta Therapeutics is 'Not Rated'. Macroaxis provides Magenta Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MGTA positions.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. In addition, we conduct extensive research on individual companies such as Magenta and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Magenta Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Magenta |
Execute Magenta Therapeutics Buy or Sell Advice
The Magenta recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Magenta Therapeutics. Macroaxis does not own or have any residual interests in Magenta Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Magenta Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Magenta Therapeutics Trading Alerts and Improvement Suggestions
| Magenta Therapeutics is not yet fully synchronised with the market data | |
| Magenta Therapeutics has some characteristics of a very speculative penny stock | |
| Magenta Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (76.46 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Magenta Therapeutics currently holds about 128.28 M in cash with (67.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.13, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 63.0% of the company shares are owned by institutional investors |
Magenta Therapeutics Returns Distribution Density
The distribution of Magenta Therapeutics' historical returns is an attempt to chart the uncertainty of Magenta Therapeutics' future price movements. The chart of the probability distribution of Magenta Therapeutics daily returns describes the distribution of returns around its average expected value. We use Magenta Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Magenta Therapeutics returns is essential to provide solid investment advice for Magenta Therapeutics.
| Mean Return | 0.12 | Value At Risk | -4.29 | Potential Upside | 5.88 | Standard Deviation | 3.69 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Magenta Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Magenta Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Magenta . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Magenta Therapeutics Buy or Sell Advice
When is the right time to buy or sell Magenta Therapeutics? Buying financial instruments such as Magenta Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Magenta Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sector ETFs Thematic Idea Now
Sector ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sector ETFs theme has 440 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sector ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Magenta Stock
If you are still planning to invest in Magenta Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Magenta Therapeutics' history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |